4//SEC Filing
Aklog Lishan 4
Accession 0001209191-22-030183
CIK 0001478069other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 5:53 PM ET
Size
5.3 KB
Accession
0001209191-22-030183
Insider Transaction Report
Form 4
CONTRAFECT CorpCFRX
Aklog Lishan
Director
Transactions
- Award
Options (Right to Buy)
2022-05-17$3.35/sh+42,000$140,700→ 42,000 totalExercise: $3.35Exp: 2032-05-17→ Common Stock (42,000 underlying)
Footnotes (1)
- [F1]Grant award made under the ContraFect Corporation 2014 Omnibus Incentive Plan. Grant vests over one year, 25% at the end of each quarter following the vesting commencement date.
Documents
Issuer
CONTRAFECT Corp
CIK 0001478069
Entity typeother
Related Parties
1- filerCIK 0001665074
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 5:53 PM ET
- Size
- 5.3 KB